• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性卵巢囊肿的液体特征:与穿刺后复发的相关性

Fluid characteristics of benign ovarian cysts: correlation with recurrence after puncture.

作者信息

Andolf E, Casslén B, Jörgensen C, Buchhave P, Lecander I

机构信息

Department of Obstetrics and Gynecology, University Hospital, Lund, Sweden.

出版信息

Obstet Gynecol. 1995 Oct;86(4 Pt 1):529-35. doi: 10.1016/0029-7844(95)00239-n.

DOI:10.1016/0029-7844(95)00239-n
PMID:7675374
Abstract

OBJECTIVE

To determine whether concentrations of gonadal steroids and fibrinolytic indices in fluid from benign ovarian cysts can discriminate between functional and neoplastic cysts and predict recurrence after ultrasound-guided puncture.

METHODS

Concentrations of gonadal steroids and components of the plasminogen-activating system were measured in cyst fluid obtained at ultrasound-guided puncture of 96 ovarian cysts and were related to subsequent cyst recurrence. In 83 patients who had surgery for benign ovarian cysts, components of the plasminogen-activating system in the cyst fluid were correlated with the histopathologic diagnosis.

RESULTS

Higher levels of plasminogen activators and lower levels of inhibitors were found in those 54 cysts that recurred after puncture and in cysts with low levels (below 2000 pmol/L) of estradiol (E2). This enzyme-inhibitor balance resulted in high fibrinolytic activity. In contrast, cysts with high E2 levels (above 2000 pmol/L) had lower levels of activators, higher levels of inhibitors, and virtually no fibrinolytic activity. A high E2 concentration in cyst fluid was the single best predictor of no recurrence after puncture. Sixteen of 18 cysts in postmenopausal women recurred, and all had low levels of E2. However, an index based on cyst fluid volume and concentrations of E2 and urokinase predicted recurrence even better. A high concentration of urokinase in the fluid correlated with neoplastic histology of the cysts obtained at laparotomy.

CONCLUSION

The fluid content of ovarian steroids and plasminogen activators and inhibitors is related to histopathology and recurrence after puncture of benign ovarian cysts. Puncture and assay of these components may minimize surgery on functional cysts.

摘要

目的

确定良性卵巢囊肿液中性腺类固醇浓度和纤溶指标能否区分功能性囊肿和肿瘤性囊肿,并预测超声引导下穿刺后的复发情况。

方法

对96例卵巢囊肿在超声引导下穿刺获取的囊肿液进行性腺类固醇浓度及纤溶酶原激活系统各成分的检测,并与后续囊肿复发情况相关联。对83例行良性卵巢囊肿手术的患者,检测囊肿液中纤溶酶原激活系统各成分,并与组织病理学诊断相关联。

结果

穿刺后复发的54个囊肿以及雌二醇(E2)水平低(低于2000 pmol/L)的囊肿中,纤溶酶原激活剂水平较高,抑制剂水平较低。这种酶-抑制剂平衡导致了高纤溶活性。相比之下,E2水平高(高于2000 pmol/L)的囊肿激活剂水平较低,抑制剂水平较高,几乎没有纤溶活性。囊肿液中高E2浓度是穿刺后无复发的唯一最佳预测指标。绝经后妇女的18个囊肿中有16个复发,且所有囊肿E2水平均低。然而,基于囊肿液体积、E2和尿激酶浓度的指标预测复发效果更好。囊肿液中高浓度尿激酶与剖腹手术获取囊肿的肿瘤组织学相关。

结论

卵巢类固醇、纤溶酶原激活剂和抑制剂的液体含量与良性卵巢囊肿穿刺后的组织病理学及复发相关。对这些成分进行穿刺和检测可减少对功能性囊肿的手术。

相似文献

1
Fluid characteristics of benign ovarian cysts: correlation with recurrence after puncture.良性卵巢囊肿的液体特征:与穿刺后复发的相关性
Obstet Gynecol. 1995 Oct;86(4 Pt 1):529-35. doi: 10.1016/0029-7844(95)00239-n.
2
Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.卵巢癌患者血液和肿瘤液中的纤溶酶原激活剂及纤溶酶原激活剂抑制剂
Eur J Cancer. 1994;30A(9):1302-9. doi: 10.1016/0959-8049(94)90178-3.
3
Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids.纤溶酶原激活物参与良性和恶性卵巢肿瘤囊液中血管抑素的生成。
Int J Oncol. 2014 Apr;44(4):1394-400. doi: 10.3892/ijo.2014.2303. Epub 2014 Feb 14.
4
Clinical value of components of the plasminogen activation system in ovarian cyst fluid.纤溶酶原激活系统各组分在卵巢囊肿液中的临床价值。
Anticancer Res. 2002 Jan-Feb;22(1A):275-82.
5
Plasminogen activators in synovial fluid and plasma from patients with arthritis.关节炎患者滑液和血浆中的纤溶酶原激活剂
Ann Rheum Dis. 1992 Aug;51(8):965-8. doi: 10.1136/ard.51.8.965.
6
Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer.尿激酶型和组织型纤溶酶原激活剂及其1型抑制剂在乳腺癌中的临床相关性。
Semin Thromb Hemost. 1991 Jul;17(3):303-12. doi: 10.1055/s-2007-1002624.
7
Fibrinolytic components in fetal membranes and amniotic fluid.
Am J Obstet Gynecol. 1993 Apr;168(4):1283-9. doi: 10.1016/0002-9378(93)90381-r.
8
Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.在22种人类肿瘤细胞系中分析纤溶酶原激活剂和抑制剂的蛋白质及信使核糖核酸水平。
Cancer Res. 1990 Mar 1;50(5):1488-94.
9
Selection of criteria for the treatment of ovarian cysts on the bases of ultrasound and cytology.基于超声和细胞学检查结果选择卵巢囊肿的治疗标准。
Gynecol Obstet Invest. 1996;42(4):244-8. doi: 10.1159/000291973.
10
Microplate immunocapture assay for plasminogen activators and their specific inhibitors.用于纤溶酶原激活剂及其特异性抑制剂的微孔板免疫捕获测定法。
J Immunol Methods. 1987 Dec 24;105(2):245-51. doi: 10.1016/0022-1759(87)90272-9.